4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-013048
CHIEF ACCOUNTING OFFICER gave up 1,383 shares (to pay taxes)
- CHIEF ACCOUNTING OFFICER acquired 581 shares (grant or award)
- CHIEF ACCOUNTING OFFICER acquired 4,707 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-07-15 | Grant or award | +581 | $12.35 | $7,175 | 13,558 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-09-01 | Option exercise | +3,933 | 17,491 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-09-01 | Shares withheld for taxes | −1,155 | $17.76 | $20,513 | 16,336 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-09-02 | Option exercise | +774 | 17,110 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-09-02 | Shares withheld for taxes | −228 | $17.76 | $4,049 | 16,882 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-09-01 | Option exercise · Restricted Share Unit | −3,933 | 11,797 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-09-01 | Grant or award · Restricted Share Unit | +10,230 | 10,230 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-09-01 | Grant or award · Share Option | +20,459 | 20,459 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-09-02 | Option exercise · Restricted Share Unit | −774 | 1,549 | D | ||
Loading xslF345X05/form4-09062023_110926.xml…